Clinical management of COVID-19 interim guidance
The Strategic preparedness and response plan outlines WHO’s strategic objectives to end the COVID-19 pandemic and assists national stakeholders with developing a structured approach to their response. The World Health Organization’s (WHO) main objectives for COVID-19 are to:
1) slow and stop transmission;
2) provide optimized care for all patients; and
3) minimize the impact of the epidemic on health systems, social services and economic activity.
To achieve these objectives, the WHO Operational considerations for case management of COVID- 19 in health facility and community describes key actions that should be taken in each transmission scenario: no cases; sporadic cases; clusters of cases; and community transmission, in order to enable timely surge of clinical and public health operations.
This guidance, Clinical management of COVID-19, is based on the above strategic priorities, and is intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen frontline clinical management. Considerations for special and vulnerable populations, such as paediatric patients, older people and pregnant women, are highlighted throughout the text.
In this document we refer to the COVID-19 care pathway. This describes a coordinated and multidisciplinary care pathway that a patient enters after s/he is screened to be a suspect COVID-19 case, and follows the continuum of their care until release from the pathway. The objective is to ensure delivery of safe and quality care while stopping onwards viral transmission. All others enter the health system in the non-COVID-19 pathway. For the most up-to-date technical guidance related to the COVID-19 response, visit WHO Country & Technical Guidance.